rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1999-6-24
|
pubmed:abstractText |
In multiple myeloma (MM) patients treated with conventional chemotherapy, the attainment and duration of a plateau phase seems to affect survival more than the degree of response to initial treatment. The aims of this study are: 1) to analyze within a cohort of previously untreated MM patients the incidence and the duration of the plateau phase; 2) to correlate it with the presenting features; 3) to assess its impact on survival.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0390-6078
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
84
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
336-41
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:10190948-Adult,
pubmed-meshheading:10190948-Aged,
pubmed-meshheading:10190948-Aged, 80 and over,
pubmed-meshheading:10190948-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10190948-Female,
pubmed-meshheading:10190948-Humans,
pubmed-meshheading:10190948-Male,
pubmed-meshheading:10190948-Middle Aged,
pubmed-meshheading:10190948-Multiple Myeloma,
pubmed-meshheading:10190948-Multivariate Analysis,
pubmed-meshheading:10190948-Remission Induction,
pubmed-meshheading:10190948-Survival Analysis
|
pubmed:year |
1999
|
pubmed:articleTitle |
Plateau phase in multiple myeloma: an end-point of conventional-dose chemotherapy.
|
pubmed:affiliation |
Institute of Hematology, University of Pavia, IRCCS Policlinico San Matteo, 27100 Pavia, Italy. a.corso@smatteo.pv.it
|
pubmed:publicationType |
Journal Article
|